VTP50469 T13336
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
VTP50469 is a highly selective and orally active inhibitor of Menin-MLL interaction( Ki: 104 pM) and has potently anti-leukemia activity.
CAS nr:
2169916-18-9
Purity:
98%
Molecular Weight:
630,82
SMILES:
CC(C)N(C(C)C)C(=O)C1=C(C=CC(=C1)F)OC2=CN=CN=C2N3CC4(C3)CCN(CC4)CC5CCC(CC5)NS(=O)(=O)C
Formula:
C32H47FN6O4S
Pathway:
Chromatin/Epigenetic,Chromatin/Epigenetic,Apoptosis
Target:
Epigenetic Reader Domain,Histone Methyltransferase,Apoptosis
